CD19 and myeloid sarcoma: However, another experiment yielded opposite results, where injection of anti-CD19 CAR-T cells led to worsening of EAE after 2 weeks, with a broader spectrum of pathological demyelination and axonal loss, despite assisting in the clearance of meningeal B-cell deposits involved in MS immunopathology [132].